Compromising muscle glucose uptake through mitigating GLUT4 and AMPK is another mechanism that MST can use to worsen metabolic disorders related to obesity [72]. This evidence concerns the gene SLC2A4 and obesity due to melanocortin 4 receptor deficiency.